Anuh Pharma Management

Management criteria checks 3/4

Wir verfügen derzeit nicht über ausreichende Informationen über den CEO.

Key information

Ritesh Shah

Chief executive officer

₹6.3m

Total compensation

CEO salary percentage	70.5%
CEO tenure	7.7yrs
CEO ownership	2.3%
Management average tenure	6.9yrs
Board average tenure	7.7yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Ritesh Shah's remuneration changed compared to Anuh Pharma's earnings?
Date	Total Compensation	Salary	Company Earnings
Dec 31 2023	n/a	n/a	₹543m
Sep 30 2023	n/a	n/a	₹445m
Jun 30 2023	n/a	n/a	₹406m
Mar 31 2023	₹6m	₹4m	₹362m
Dec 31 2022	n/a	n/a	₹355m
Sep 30 2022	n/a	n/a	₹336m
Jun 30 2022	n/a	n/a	₹323m
Mar 31 2022	₹4m	₹4m	₹306m
Dec 31 2021	n/a	n/a	₹225m
Sep 30 2021	n/a	n/a	₹193m
Jun 30 2021	n/a	n/a	₹173m
Mar 31 2021	₹3m	₹3m	₹284m
Dec 31 2020	n/a	n/a	₹266m
Sep 30 2020	n/a	n/a	₹288m
Jun 30 2020	n/a	n/a	₹252m
Mar 31 2020	₹4m	₹4m	₹143m
Dec 31 2019	n/a	n/a	₹205m
Sep 30 2019	n/a	n/a	₹196m
Jun 30 2019	n/a	n/a	₹235m
Mar 31 2019	₹3m	₹3m	₹234m
Dec 31 2018	n/a	n/a	₹213m
Sep 30 2018	n/a	n/a	₹208m
Jun 30 2018	n/a	n/a	₹160m
Mar 31 2018	₹2m	₹2m	₹165m

Vergütung im Vergleich zum Markt: RiteshDie Gesamtvergütung ($USD75.68K) liegt unter dem Durchschnitt von Unternehmen ähnlicher Größe auf dem Markt Indian ($USD194.56K).

Entschädigung vs. Einkommen: RiteshDie Bezüge der Mitarbeiter sind im vergangenen Jahr um mehr als 20 % gestiegen.

CEO

Ritesh Shah (42 yo)

7.7yrs

Tenure

₹6,310,088

Compensation

Mr. Ritesh Bipin Shah, MBA, serves as Joint Managing Director at Anuh Pharma Limited since January 8, 2021 until 2021. Mr. Shah served as Chief Executive Officer until January 8, 2021 at Anuh Pharma Ltd an...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Ritesh Shah	Joint MD & Executive Director	no data	₹6.31m	2.31% ₹ 288.9m
Vivek Shah	Joint MD & Executive Director	3.3yrs	₹6.23m	2.33% ₹ 292.6m
Bipin Shah	Non-Executive Vice Chairman of the Board	36.6yrs	₹365.00k	14.68% ₹ 1.8b
Darshan Rampariya	Chief Financial Officer	9.9yrs	₹3.24m	no data
Rajiv Sutar	Vice President of Technical	3.9yrs	no data	no data
Rajendrakumar Kotadia	Vice President of Marketing	no data	no data	no data
Gaurav Shah	Head of Anti Malerials & Non Executive Non Independent Director	no data	no data	3.19% ₹ 400.2m
Uday Korgaonkar	Head of the Department - R&D	no data	no data	no data

6.9yrs

Average Tenure

50.5yo

Average Age

Erfahrenes Management: Das Managementteam von 506260 ist erfahren und erfahren (durchschnittliche Amtszeit: 6.8 Jahre).

Board Members

Name	Position	Tenure	Compensation	Ownership
Ritesh Shah	Joint MD & Executive Director	7.7yrs	₹6.31m	2.31% ₹ 288.9m
Vivek Shah	Joint MD & Executive Director	7.6yrs	₹6.23m	2.33% ₹ 292.6m
Bipin Shah	Non-Executive Vice Chairman of the Board	36.6yrs	₹365.00k	14.68% ₹ 1.8b
Gaurav Shah	Head of Anti Malerials & Non Executive Non Independent Director	less than a year	no data	3.19% ₹ 400.2m
Arun Todarwal	Non- Independent & Non- Executive Chairman	15.5yrs	₹490.00k	0.0022% ₹ 275.7k
Bharat Shah	Non-Executive Director	43.5yrs	₹240.00k	3.73% ₹ 466.9m
Jasvantlal Shah	Independent Director	28.7yrs	₹490.00k	0.0092% ₹ 1.2m
Ketan Shah	Non-Executive Director	7.7yrs	₹140.00k	0.48% ₹ 59.9m
Samir Shah	Non-Executive Director	7.7yrs	₹35.00k	1.72% ₹ 215.7m
Sandeep Joshi	Independent Director	4.7yrs	₹140.00k	no data
Mita Dixit	Independent Non-Executive Woman Director	5.2yrs	₹175.00k	0.00014% ₹ 17.5k
Harmanbhai Patel	Independent Non-Executive Director	4.9yrs	₹315.00k	no data

7.7yrs

Average Tenure

62yo

Average Age

Erfahrener Vorstand: 506260Die Vorstandsmitglieder gelten als erfahren (7.3 Jahre durchschnittliche Amtszeit).

Anuh Pharma Management

Management criteria checks 3/4

Key information

Recent management updates

Anuh Pharma Limited Appoints Manan Jayesh Vadhan as Company Secretary and Compliance Officer

Anuh Pharma Limited Announces Resignation of Jinal Dharmil Mehtalia as Company Secretary and Compliance Officer, Effective 14 February, 2024

Anuh Pharma Limited Announces the Resignation of Hemant Aunt as Company Secretary and Compliance Officer

Anuh Pharma Limited Announces Appointment of Ms. Jinal Ajay Shah as Company Secretary and Compliance Officer, Effective from 15 January 2024

Anuh Pharma Limited Approves the Board Appointments

Anuh Pharma Limited Approves Board Appointments

Recent updates

Anuh Pharma Limited Appoints Manan Jayesh Vadhan as Company Secretary and Compliance Officer

Investor sentiment improves as stock rises 16%

Investor sentiment improves as stock rises 20%

New minor risk - Share price stability

Anuh Pharma Limited Announces Resignation of Jinal Dharmil Mehtalia as Company Secretary and Compliance Officer, Effective 14 February, 2024

Third quarter 2024 earnings released: EPS: ₹3.81 (vs ₹1.86 in 3Q 2023)

Anuh Pharma Limited to Report Q3, 2024 Results on Feb 09, 2024

Anuh Pharma Limited Announces the Resignation of Hemant Aunt as Company Secretary and Compliance Officer

Anuh Pharma Limited Announces Appointment of Ms. Jinal Ajay Shah as Company Secretary and Compliance Officer, Effective from 15 January 2024

Anuh Pharma Limited Approves the Board Appointments

Investor sentiment improves as stock rises 21%

Second quarter 2024 earnings released: EPS: ₹2.76 (vs ₹1.98 in 2Q 2023)

Anuh Pharma Limited to Report Q2, 2024 Results on Nov 10, 2023

Anuh Pharma Limited Approves Board Appointments

New minor risk - Share price stability

Anuh Pharma Limited to Report Q1, 2024 Results on Aug 11, 2023

Upcoming dividend of ₹2.00 per share at 1.5% yield

Full year 2023 earnings released: EPS: ₹7.22 (vs ₹6.10 in FY 2022)

Anuh Pharma Limited, Annual General Meeting, Aug 10, 2023

Investor sentiment improves as stock rises 25%

Full year 2023 earnings released: EPS: ₹7.22 (vs ₹6.10 in FY 2022)

Anuh Pharma Limited Announces Board Changes

Anuh Pharma Limited to Report Q4, 2023 Results on May 19, 2023

Third quarter 2023 earnings released: EPS: ₹1.86 (vs ₹1.49 in 3Q 2022)

Anuh Pharma Limited Announces Resignation of Lalitkumar P Shah as Non-Executive Director

Anuh Pharma Limited to Report Q3, 2023 Results on Feb 10, 2023

Anuh Pharma Limited Approves Appointment of Hemant Auti as the Company Secretary & Compliance Officer

Less than half of directors are independent

Second quarter 2023 earnings released: EPS: ₹1.98 (vs ₹1.72 in 2Q 2022)

Anuh Pharma Limited Announces Resignation of Bharat Gangani as Company Secretary and Compliance Officer

Anuh Pharma Limited Approves Final Dividend for the Financial Year Ended 2021-2022

Investor sentiment improved over the past week

Anuh Pharma Limited to Report Q1, 2023 Results on Aug 05, 2022

Upcoming dividend of ₹1.75 per share

Full year 2022 earnings released

Anuh Pharma Limited, Annual General Meeting, Aug 05, 2022

Anuh Pharma Limited Recommends Final Dividend for the Financial Year Ended 31 March 2022

Anuh Pharma Limited to Report Q4, 2022 Results on May 14, 2022

Less than half of directors are independent

Investor sentiment improved over the past week

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Anuh Pharma Limited to Report Q2, 2022 Results on Feb 04, 2022

Second quarter 2022 earnings released: EPS ₹1.72 (vs ₹1.32 in 2Q 2021)

Upcoming dividend of ₹1.50 per share

Full year 2021 earnings released: EPS ₹5.68 (vs ₹2.86 in FY 2020)

Insider recently sold ₹1.3m worth of stock

Full year 2021 earnings released

Anuh Pharma Limited Recommends Final Dividend

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

New 90-day low: ₹109

Third quarter 2021 earnings released: EPS ₹0.83 (vs ₹1.27 in 3Q 2020)

New 90-day low: ₹115

Anuh Pharma Limited to Report Q3, 2021 Results on Feb 09, 2021

Anuh Pharma Limited Announces Executive Changes

New 90-day low: ₹138

New 90-day low: ₹147

Second quarter 2021 earnings released: EPS ₹1.32

Market pulls back on stock over the past week

First quarter earnings released

New 90-day high - ₹247

CEO Compensation Analysis

CEO

Tenure

Compensation

Leadership Team

Average Tenure

Average Age